Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Operable Breast Cancer”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Not applicableActive Not RecruitingNCT04897009
What this trial is testing

Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer

Who this might be right for
Invasive Breast Carcinoma
Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00422903
What this trial is testing

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 92
Testing effectiveness (Phase 2)Study completedNCT03272477
What this trial is testing

Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients

Who this might be right for
Breast Neoplasms
Palleos Healthcare GmbH 257
Testing effectiveness (Phase 2)Study completedNCT02400567
What this trial is testing

Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women

Who this might be right for
Neoadjuvant Operable Breast Cancer
UNICANCER 125
Not applicableUnknownNCT01850628
What this trial is testing

NSABP Biospecimen Discovery Project

Who this might be right for
Breast Cancer
NSABP Foundation Inc 50
Not applicableLooking for participantsNCT04281641
What this trial is testing

Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Fudan University 94
Testing effectiveness (Phase 2)Study completedNCT00301548
What this trial is testing

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma
European Institute of Oncology 172
Large-scale testing (Phase 3)Study completedNCT00513292
What this trial is testing

Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery

Who this might be right for
HER2/Neu PositiveStage IA Breast CancerStage IB Breast Cancer+2 more
National Cancer Institute (NCI) 280
Testing effectiveness (Phase 2)Temporarily pausedNCT02897050
What this trial is testing

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 170
Not applicableUnknownNCT03647280
What this trial is testing

The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Large-scale testing (Phase 3)Active Not RecruitingNCT03168880
What this trial is testing

Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Tata Memorial Hospital 720
Testing effectiveness (Phase 2)Study completedNCT00933517
What this trial is testing

Assessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer.

Who this might be right for
Pathological Response Rate
Centre Jean Perrin 62
Large-scale testing (Phase 3)Study completedNCT00038402
What this trial is testing

Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 74
Testing effectiveness (Phase 2)Study completedNCT00191789
What this trial is testing

Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 65
Not applicableEnded earlyNCT01007890
What this trial is testing

Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer

Who this might be right for
Breast Cancer
Precision Therapeutics 134
Not applicableStudy completedNCT00437853
What this trial is testing

Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer

Who this might be right for
Breast Cancer
Instituto Nacional de Cancerologia de Mexico 30
Large-scale testing (Phase 3)Study completedNCT03969121
What this trial is testing

Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

Who this might be right for
Breast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of Breast
Kyoto Breast Cancer Research Network 141
Testing effectiveness (Phase 2)Study completedNCT00450892
What this trial is testing

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 129
Testing effectiveness (Phase 2)Ended earlyNCT00589238
What this trial is testing

Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 16
Load More Results